Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial of Vedolizumab given via multiple intravenous doses in patients with Ulcerative Colitis has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab [Phase 4]
A Phase 4 clinical trial update evaluating Golimumab for ulcerative colitis, incorporating Physiological Intermolecular Modification Spectro…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D [NA]
This clinical trial update notes the completion of a study evaluating supplementation with Vitamin D3 (cholecalciferol) in patients with inf…
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Efficacy of Infliximab as a Rescue Therapy in Pediatric Acute Severe Colitis
This completed trial evaluates infliximab as a rescue therapy for children with acute severe colitis. The update reports on the efficacy out…
-
CLINICAL_TRIALS research · 2014-06-09Clinical Trial Update: FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
This is a completed clinical trial update (FOCUS) evaluating fecal calprotectin for the diagnosis and management of inflammatory bowel disea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets [Phase 3]
Phase 3 trial results for oral budesonide-MMX 9mg extended-release tablets in ulcerative colitis have been completed with results posted in …
-
FDA approval · 2014-05-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited under BLA125057.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders
This completed clinical trial analyzed advanced metagenomic profiles of the human colonic microbiota in patients with chronic GI disorders a…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness [NA]
A completed clinical study examining neuropsychiatric symptoms in pediatric inflammatory bowel disease and related depression.
-
FDA approval · 2014-05-20FDA Approved: ENTYVIO — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved Entyvio (vedolizumab) in its original application for treatment of moderate-to-severe Crohn's disease and ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis [Phase 2]
Phase 2 study evaluating efficacy, pharmacodynamics, safety and tolerability of oral BL-7040 in moderately active ulcerative colitis. Result…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of GLPG0974 in adults with Ulcerative Colit…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Ulcerative Colitis Relapse Prevention Trial, Hypnosis [NA]
A completed clinical trial from Northwestern University evaluated hypnosis as a relapse-prevention strategy for ulcerative colitis and infla…
-
CLINICAL_TRIALS research · 2014-03-28Clinical Trial Update: Cost-effectiveness of TPMT Pharmacogenetics [NA]
A completed study evaluating the cost-effectiveness of TPMT pharmacogenetic testing in inflammatory bowel diseases, including Crohn's diseas…
-
EMA approval · 2014-03-21European Medicines Agency recommends approval of a locally targeted treatment for ulcerative colitis and Crohn's disease
The European Medicines Agency recommends approval of a locally targeted treatment for ulcerative colitis and Crohn's disease.
-
FDA approval · 2014-03-14FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for LIALDA (mesalamine) from Takeda Pharmaceuticals America, Inc. The action likely updates the …
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating an oral anti-TNF antibody in patients with active ulcerative col…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2, Phase 3]
The document reports on a phase 2/3 clinical trial of golimumab for moderately to severely active ulcerative colitis, presenting efficacy an…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Exacerbating Factors in Inflammatory Bowel Disease
The document provides an update on a completed clinical trial examining factors that exacerbate inflammatory bowel disease, including ulcera…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery [NA]
A terminated clinical trial evaluating SprayShield to reduce post-operative adhesion formation after major open abdominal surgery, with resu…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Cognition and Emotion in the SII and IBD [NA]
A completed clinical trial investigating cognition and emotion in irritable bowel syndrome and inflammatory bowel disease (including Crohn's…
-
CLINICAL_TRIALS research · 2014-01-08Clinical Trial Update: Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update comparing Zoenasa to Mesalamine Enema for left-sided/distal ulcerative colitis; the document does not provide …
-
CLINICAL_TRIALS research · 2014-01-07Clinical Trial Update: Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit
A clinical trial update examining gastrointestinal transit times and motility in patients with severe ulcerative colitis using the Motilis-3…
-
CLINICAL_TRIALS research · 2014-01-07Clinical Trial Update: Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit
This clinical trial update from the University of Aarhus investigates gastrointestinal motility in severe ulcerative colitis using Motilis-3…
-
FDA approval · 2014-01-02FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for CANASA (mesalamine) filed by Allergan, Inc.